Novartis is a holding company. Through its subsidiaries, Co. is a multinational group of companies focusing on the research, development, manufacturing and marketing of a range of pharmaceuticals and generic medicines. Co. comprises two divisions: Innovative Medicines, which researches, develops, manufactures, distributes and sells patented pharmaceuticals; and Sandoz, which develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients, and has three franchises, Retail Generics, Anti-Infectives and Biopharmaceuticals.
|
|
Free NVS Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.60 out of 4) 8th percentile
(ranked lower than approx. 92% of all stocks covered)
Analysts' Target Price: NVS Stock Forecast Based on Zacks ABR data; powered by Xignite |